Survey							
                            
		                
		                * Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Absorption Affected by: 1. Physiological factors  route of administration  drug distribution 2. Drug chemical physical properties  dissolution rate (solids)  hydrophilicity/hydrophobicity B. Amsden CHEE 440 Pathways of Oral Absorption Two main mechanisms of transport across the gastrointestinal membrane: 1. 2. Transcellular diffusion Paracellular diffusion B. Amsden CHEE 440 Transcellular Diffusion The transcellular pathway is composed of 3 mechanisms: passive diffusion, carrier-mediated transport, endocytosis Passive diffusion dm AK o / w DA,BCd  C r   dt x  B. Amsden CHEE 440 Partition coefficient, Ko/w  for absorption into cell, drug must pass through lipid cell membrane  consider two immiscible phases (oil and water) and a drug which is soluble in both (ex. cyclosporine), at equilibrium. oil water a c, o  cons tan t a c ,w ideal and ideally dilute solutions : drug oil  K o/ w  drug wat er B. Amsden CHEE 440 Clinical Significance of Ko/w prediction of absorption of drugs through various tissues  absorption of acidic drugs from colon log %abs  0.156pKa  6.8  0.366 log K o/ w  0.755  absorption of basic drugs from small intestine log %abs  0.131log K o/ w   0.362log Ko / w 2 B. Amsden CHEE 440 Partition Coefficient and Absorption Optimum Ko/w B. Amsden CHEE 440 Carrier-Mediated Transport Active transport B. Amsden CHEE 440 Drug Solubility Solubility: the extent to which a drug dissolves under a given set of conditions of solvent and temperature significance  drugs must be in solution before they can be absorbed  drugs of low aqueous solubility present formulation problems saturation concentration, Csat  limit of solubility of a solute in a solvent at a given T B. Amsden CHEE 440 Dissolution Rate important for tablets, capsules, suspensions slow dissolution rate = low bioavailability consider a solid particle in water stagnant water layer Csat C = Cb Noyes-Whitney Eqn B. Amsden dm DAC sat   kAC sat dt h CHEE 440 Dissolution Rate But, surface area changes with time; for spherical particles: kCsat t r  ro   r = radius at time t ro= initial radius  = density for N particles: M o  M  t 1 B. Amsden 3 1 3 M = mass of particles  = cube-root dissolution constant CHEE 440 Factors influencing Csat  crystal structure: polymorphism, hydrates  pH  salt form  common ion effect  co-solvents B. Amsden CHEE 440 Process of Dissolution crystal solid + solvent + dissolved solute B. Amsden CHEE 440 Crystalline Solids Have a regular, ordered structure  composed of identical repeating units - unit cell • ex. cubic, rhombic, tetragonal Have distinct melting pts (Tf). Strength of bonds between atoms, molecules determines :  geometry of unit cell  Tf, Hf Hf Tf  T   ln X2    R  Tf T  B. Amsden CHEE 440 Crystalline Solids Electrostatic, Covalent Bonds  ex. NaCl, graphite (C4)  strong bonds - cubic unit cell  hi Tf, hi Hf (eg. Tf= 801°C for NaCl)  stable structure  hard, brittle B. Amsden CHEE 440 Crystalline Solids Van der Waals, H-bonds  ex. organic compounds  weak bonds  low Tf, low Hf (e.g. Tf = 238°C for caffeine)  soft materials  metastable structures B. Amsden CHEE 440 Polymorphism  molecule can crystallize into more than one crystal structure  metastable form transforms to stable form over time • usually nonreversible process monotropic polymorphism  many polymorphic forms possible • progesterone - 2 • nicotinamide - 4  dissolution rate changes with polymorphic form B. Amsden CHEE 440 Amorphism      no crystal structure no distinct Tf supercooled liquids - subdued molecular motion flow under an applied pressure generally easier to dissolve B. Amsden CHEE 440 Crystal Hydrates solvent trapped when compound crystallizes - solvates  solvent is water - hydrates  no water - anhydrate solvent-compound interactions  H2O further stabilizes lattice - polymorphic solvates  H2O occupies void spaces - pseudopolymorphic solvates B. Amsden CHEE 440 Crystal Hydrates anhydrate has higher Tf, generally dissolves faster B. Amsden CHEE 440 Crystal Hydrates Significance  incorporation of H2O affects bioabsorption rate and  bioactivity B. Amsden CHEE 440 pH and drug solubility weakly acidic drug  pHp  the pH below which the drug precipitates from solution S  So   pHp  pKa  log  So  weakly basic drug  pHp  the pH above which the drug precipitates from solution  So   pHp  pKw  pK b  log  S So  B. Amsden CHEE 440 Drug Salt Form salt solubility depends on nature of counter-ion B. Amsden CHEE 440 Slightly Soluble Electrolytes ex. Al(OH)3, Ca2CO3, ZnO, drug salts AgCl(s)  Ag+(L) + Cl-(L) Ksp = [Ag+] [Cl-] = 1.25(10-10) at 25°C Al(OH)3  Al3+(L) + 3OH-(L) Ksp = [Al3+] [OH-]3 = 7.7(10-13) at 25°C beware of common ion effect (salting-out) B. Amsden CHEE 440 Other solubility issues Cosolvents  solvents which, when combined, increase the solubility of a given compound • ex. phenobarbital in water has a solubility of 0.1g/100 ml, in alcohol 1 g in 10 ml, and in 20% alcohol/water 0.3 g/100 ml Combined effect of pH and cosolvent  adding alcohol to buffered solution of weak electrolyte increases solubility of undissociated form  decreases pHp for a weakly acidic drug B. Amsden CHEE 440 pH and Ko/w Dissociated portion of drug does not dissolve in oil phase. Partition coefficient HA o K o/ w  HA w Apparent partition coefficient HAo K app  HA w  A w B. Amsden CHEE 440 pH and Ko/w As pH changes, [HA]w changes: weak acid : weak base : B. Amsden 1   log K  log K app  log 1 10pH pK a  1   log K  log K app  log 1 10pKa pH  CHEE 440 Summary Absorption of drug is influenced by combination of permeability and solubility Implications of Low Drug Permeability  incomplete absorption  rapid, complete dissolution needed  release may need to be modified  increase exposure to an absorption window  possible retarded release if a saturable transport phenomenon exists Implications of Low Drug Solubility • poor absorption • may need co-solvent or penetration enhancer B. Amsden CHEE 440